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Cells are equipped withmechanisms that allow them to rapidly detect and respond to viruses. These defense
mechanisms rely partly on receptors that monitor the cytosol for the presence of atypical nucleic acids asso-
ciated with virus infection. RIG-I-like receptors detect RNA molecules that are absent from the uninfected
host. DNA receptors alert the cell to the abnormal presence of that nucleic acid in the cytosol. Signaling
by RNA and DNA receptors results in the induction of restriction factors that prevent virus replication and
establish cell-intrinsic antiviral immunity. In light of these formidable obstacles, viruses have evolved mech-
anisms of evasion, masking nucleic acid structures recognized by the host, sequestering themselves away
from the cytosol or targeting host sensors, and signaling adaptors for deactivation or degradation. Here,
we detail recent advances in the molecular understanding of cytosolic nucleic acid detection and its evasion
by viruses.Cell-Intrinsic Antiviral Immunity
Virus infections can have devastating consequences for the host
and must therefore be resisted quickly and effectively. A cell-
intrinsic ability to restrict viral infection is found in all domains
of life. This form of immunity is mediated by restriction factors
that bind viral components and inhibit viral replication. Verter-
brate cells have evolved a vast arsenal of viral restriction factors
that directly inhibit all steps of viral replication (Duggal and Emer-
man, 2012; Yan and Chen, 2012; Garcı´a-Sastre, 2011) (Figure 1).
For instance, cytoplasmic entry of viruses such as influenza A vi-
rus, West Nile virus (WNV), and Dengue virus (DENV) is restricted
by IFITM (interferon [IFN]-inducible transmembrane) proteins,
whereas incoming retroviruses, such as HIV-1, are blocked by
the capsid-binding protein TRIM5a (tripartite motif protein 5a)
(Yan and Chen, 2012). When viral entry cannot be prevented,
host factors inhibit subsequent steps in the viral life cycle. Mx
(myxovirus resistance) GTPases form oligomeric structures
that trap and degrade viral nucleocapsids and polymerases after
infection with orthomyxoviruses, such as influenza (Yan and
Chen, 2012). Host deaminases, including APOBEC3 (apolipo-
protein B mRNA-editing enzyme, catalytic polypeptide 3) and
ADAR-1 (adenosine deaminase, RNA-specific 1) mutagenize
viral genomes. The deoxynucleoside triphosphate triphosphohy-
drolase SAMHD1 (SAM-domain- and HD-domain-containing
protein) degrades deoxynucleoside triphosphates and prevents
reverse transcription of retroviruses (Duggal and Emerman,
2012; Yan and Chen, 2012). Viral protein synthesis is inhibited
by antiviral proteins such as IFIT (interferon-induced protein
with tetratricopeptide repeats) or Schlafen 11, whereas viperin
and tetherin prevent assembly and release of progeny virions
(Duggal and Emerman, 2012; Yan and Chen, 2012). Thus, cell-
intrinsic antiviral immunity acts as a major barrier to infection,
which must be circumvented for any virus to become a success-
ful pathogen.
Cell-intrinsic antiviral effector proteins exert their function by
targeting different viral components. However, their ability to
discriminate virus from host is often imperfect or lacking alto-
gether. For example, PKR (protein kinase R) causes a globalshutdown in protein translation, and RNaseL (ribonuclease L)
cleaves both viral and host RNA (Garcı´a-Sastre, 2011). This
lack of specificity allows both PKR and RNaseL to act as effec-
tive host restriction factors for a vast array of viruses but at a se-
vere cost to the infected cell. So that detrimental effects on the
uninfected host can be avoided, the activities of antiviral factors
must be tightly regulated. This is typically achieved in two ways:
first, antiviral effectors are not constitutively active and require a
virus trigger (viral protein, viral genome, etc.) to exert their func-
tion; second, the expression of antiviral effectors is maintained at
very low levels in the steady state and is upregulated only in
response to IFN produced after viral infection. Type III (IFN-l)
and type I (mainly IFN-a and IFN-b) IFNs can be produced by
all cell types upon virus infection and, once secreted, communi-
cate a state of antiviral alertness to surrounding cells by inducing
the expression of hundreds of IFN-stimulated genes (ISGs). Most
cell-intrinsic viral restriction factors are ISGs, thereby ensuring
that their expression is restricted to the infected state (Figure 1).
ISGs further include proteins, such as costimulatory molecules,
cytokines, and chemokines, that favor the initiation of adaptive
immune responses. Thus, type I and type III IFNs act as the pri-
mary switch for initiating antiviral immunity in vertebrates.
The importance of type I and type III IFNs and the fact that they
are produced upon infection have naturally led to interest in the
mechanisms that cells use to detect viral presence. Research in
this field first uncovered amechanism utilizingmembrane-bound
Toll-like receptors (TLRs) for detecting extracellular viruses and
virus-infected cells (Takeuchi and Akira, 2010). These pattern-
recognition receptors (PRRs) detect viral pathogen-associated
molecular patterns (PAMPs), such as viral proteins or viral
nucleic acids, that are found in the extracellular milieu or within
endosomes and then signal to the nucleus to induce transcrip-
tion of IFNs and other genes encoding antiviral or proinflamma-
tory mediators. Yet, the topology (extracellular facing) and
restricted expression of TLRs (mostly leukocytes) cannot ac-
count for the fact that all cells can produce IFNs in response to
direct infection. The latter involves a cytosolic mode of virus
detection that has been recognized since the discovery of IFNsImmunity 38, May 23, 2013 ª2013 Elsevier Inc. 855
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Figure 1. Cell-Intrinsic Restriction and Recognition of Viruses
Cells express many intrinsic antiviral restriction factors capable of blocking
different stages of the virus replication cycle. They are also equiped with PRRs
that detect viral PAMPs and trigger the expression of cytokines, including type
I IFNs (IFN-a and IFN-b). IFNs signal via the interferon receptor (IFNAR) and
upregulate the expression of hundreds of ISGs, including the antiviral factors
and PRRs themselves, as well as proteins important in regulating immune
responses.
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Figure 2. Domain Architecture of RLRs andModel of RLR Activation
(A) The three mammalian RLRs (RIG-I, MDA5, and LGP2) are superfamily 2
DExD/H-box RNA helicases. RLRs have a similar helicase core, which com-
prises two helicase domains termed Hel1 and Hel2, as well as an insertion
domain within Hel2 known as Hel2i. At the C terminal of the Hel2 is a pincer (P)
domain, also known as the bridging helices. All three RLRs also share a
C-terminal domain (CTD), but only RIG-I and MDA5 have two N-terminal
tandem CARDs (CARD1 and CARD2).
(B) ATP-dependent conformational changes and activation of RIG-I andMDA5
occur after the recognition of stimulatory RNAs, such as base-paired 50 PPP
RNA (50 PPP is represented by the red dot) and long dsRNA, respectively.
Whereas RIG-I binds to the 50 PPP end of base-paired RNA, MDA5 binds the
stem-loop and cooperatively assembles in a head-to-tail fashion along the
length of dsRNA to form a filament-like structure. K63 polyubiquitylation and
oligomerization of RLRs are thought to promote downstream signaling.
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to be understood at the molecular level. The receptors involved
include the RIG-I-like receptors (RLRs), which detect viral RNA in
the cytosol, as well as cGAS (cyclic GMP-AMP synthase), IFI16
(IFN gamma-inducible protein 16), DAI (DNA-dependent acti-
vator of IFN-regulatory factors), and several other cytosolic pro-
teins that detect DNA (see also the accompanying review by
Paludan and Bowie, 2013, in this issue of Immunity). Here, we re-
view recent progress in our understanding of cell-intrinsic detec-
tion of viruses by RLRs and DNA sensors and its consequences
for the control of virus infection.
RLRs Are Superfamily 2 DExD/H-Box RNA Helicases
The three central members of the mammalian RLR family, RIG-I
(retinoic acid-inducible gene I), MDA5 (melanoma differentiation
factor 5), and LGP2 (laboratory of genetics and physiology 2), are
found in the cytosol of most cell types and are strongly induced
by IFNs in a positive-feedback loop of virus detection (Takeuchi
and Akira, 2010) (Figure 1). They belong to the DExD/H-box fam-
ily of helicases, which in turn is part of helicase superfamily 2
(DExD/H refers to Asp-Glu-x-Asp/His, and ‘‘x’’ can be any amino
acid) (Luo et al., 2013). Like other helicases, RLRs possess a
conserved helicase core comprising two highly similar tandem
helicase domains (Hel1 and Hel2) separated by a unique inser-
tion (known as Hel2i) that is important for RNA-triggered signal
integration (Luo et al., 2013) (Figure 2A). Although RNA helicases
were originally named for their ability to unwind double-stranded
(ds) RNA, they perform more general functions such as displac-
ing RNA-bound proteins, annealing RNA strands, and promoting856 Immunity 38, May 23, 2013 ª2013 Elsevier Inc.RNA conformational changes (Luo et al., 2013). This is true of
RIG-I, which has been shown to unwind RNA duplexes and
translocate along base-paired RNA (Leung and Amarasinghe,
Immunity
Review2012). In addition to having a helicase domain, RIG-I, MDA5, and
LGP2 all have a C-terminal domain (CTD), which confers part of
their ligand specificity (further detail below). Finally, RIG-I and
MDA5, but not LGP2, have at their N terminus two adjacent
CARD (caspase activation and recruitment) domains, which
are key for coupling to downstream signaling adaptors
(Figure 2A).
Sensing Viruses by RLRs
Studies in RLR-deficient mice and cells have demonstrated
essential and differential requirements for RIG-I, MDA5, and
LGP2 in combating viral infection (Table S1, available online).
RIG-I is required for type I IFN production in response to New-
castle disease virus, vesicular stomatitis virus, influenza, and
Japanese encephalitis virus (Kato et al., 2005; 2008; Loo et al.,
2008; Yoneyama et al., 2005). In contrast, IFN production is
impaired in MDA5-deficient, but not RIG-I-deficient, cells in-
fected with Picornaviridae (Feng et al., 2012; Gitlin et al., 2006;
Kato et al., 2006) (Table S1). Both the murine norovirus 1 and
the murine hepatitis virus also trigger an MDA5-dependent IFN
response (McCartney et al., 2008; Roth-Cross et al., 2008;
Zu¨st et al., 2011). Some viruses such as WNV and DENV are
recognized by both MDA5 and RIG-I (Fredericksen et al., 2008;
Loo et al., 2008; Schoggins et al., 2011). Finally, the IFN response
to some DNA viruses is variably reported to be dependent on
RIG-I and/or MDA5 (Table S1). In addition to being important
for combating viruses, RIG-I and MDA5 have been implicated
in the sensing of bacteria (Table S1).
In contrast to those of MDA5 and RIG-I, the role of LGP2 (en-
coded by Dhx58) in cytosolic RNA sensing remains unclear.
Some reports suggest that LGP2 is required for type I IFN
production in response to some RIG-I- and MDA5-dependent
viruses (Table S1), whereas others describe LGP2 as a negative
regulator of RIG-I-dependent responses (Bruns and Horvath,
2012). Further work will be required for resolving these discrep-
ancies and understanding the function of LGP2 in antiviral
immunity.
RNA Structures Recognized by RLRs
The viral specificity of RLRs reflects the remarkable capacity of
these helicases to detect RNAs that are present only in infected
cells. How RLRs discriminate such RNAs from those present in
uninfected conditions remains a topic of intense investigation
and has led to the identification of specific primary, secondary,
or tertiary structures, as well as modifications in viral or cellular
RNAs, that dictate RLR recognition.
The agonist for RIG-I has been defined as an RNA with a
triphosphate (PPP) moiety and blunt-ended base-paired region
of 20 nt at the 50 end (Hornung et al., 2006; Pichlmair et al.,
2006; Schlee et al., 2009; Schmidt et al., 2009). Base pairing at
the 50 end can occur intramolecularly, on individual single-
stranded (ss) RNA molecules that possess appropriate second-
ary structures, or intermolecularly between two complementary
RNA molecules that form dsRNA. In either case, the 50 PPP re-
mains essential. Indeed, thermodynamic analysis revealed that
full-length RIG-I recognizes RNA with a 50 PPP with an affinity
that is 126-fold higher than that for RNA with a 50 hydroxyl group
(Vela et al., 2012). This specificity has further been validated in
recent structural studies that show a pocket for 50 PPP withinthe CTD of RIG-I (Leung and Amarasinghe, 2012). The require-
ment for 50 PPP provides a mechanism for virus self-discrimina-
tion by RIG-I. Although host RNA transcripts initially contain 50
PPP, the phosphates are either masked by a 7-methyl-guano-
sine cap (mRNA) or removed before export from the nucleus
(tRNA and rRNA). Thus, the cytosol of uninfected cells is devoid
of 50 PPP RNA, but this is not true of virus-infected cells. Many
RNA viruses use primer-independent mechanisms for virus repli-
cation and, consequently, possess genomes and replication in-
termediates that have a PPP-bearing nucleoside at the 50 end.
Notably, many viral genomes, including those of influenza and
rabies virus, additionally possess complementary 50 and 30
ends that hybridize to form a ‘‘panhandle’’ structure (Schlee
et al., 2009). Consistent with these two features, viral genomic
RNA was identified as the physiological RIG-I agonist in cells in-
fected with influenza and Sendai virus (Baum et al., 2010; Re-
hwinkel et al., 2010; Weber et al., 2013).
Some RNAs lacking a 50 PPP have also been proposed to act
as RIG-I agonists. Both short (25 bp) and long (>200 bp) dsRNA
with a 30 or 50 monophosphate or a 50 hydroxyl group have been
reported to activate RIG-I (Binder et al., 2011; Kato et al., 2008;
Takahasi et al., 2008). Furthermore, small structured RNaseL-
cleavage-derived RNAs with a 50 hydroxyl group and a 30 mono-
phosphate were also reported as RIG-I agonists (Malathi et al.,
2007). These types of RNAs can be shown to bind RIG-I, albeit
with lower affinities than 50 PPP base-paired RNAs (Jiang
et al., 2011a; Vela et al., 2012). These data raise the possibility
that RIG-I might in some instances recognize duplex RNA struc-
tures independently of the 50 end. In vitro reconstitution of RIG-I
signaling has confirmed that poly(I:C), a synthetic RNA often
used as a dsRNA analog, can act as a direct agonist for RIG-I
(Zeng et al., 2010).
In contrast to RIG-I agonists, MDA5 agonists in virally infected
cells are not as well understood. Picornaviruses are sensed by
MDA5 and produce abundant dsRNA during infection (Pichlmair
et al., 2009; Weber et al., 2006) (Table S1). MDA5 could therefore
act simply as a dsRNA sensor. Consistent with this notion, MDA5
binds to and is activated by poly(I:C) (Takeuchi and Akira, 2010).
Other data suggest that dsRNA recognition by MDA5 is depen-
dent on RNA length and that only relatively long poly(I:C) (0.5–7
kb) efficiently activates MDA5 (Kato et al., 2008). A recent pro-
posal is that MDA5 functions as a ‘‘molecular ruler:’’ whereas
relatively short dsRNAs (100 nt) can activate MDA5 when pre-
sent in large quantites, longer dsRNAs (1–2 kb) do so more effi-
ciently as a result of the cooperative assembly of the helicase
along dsRNA stems, the complex created by which forms fila-
mentous oligomers that are important for signaling (see below)
(Berke and Modis, 2012; Berke et al., 2012; Feng et al., 2012;
Peisley et al., 2012; 2011; Wu et al., 2013a). Consistent with
such a proposal, long dsRNA generated after encephalomyocar-
ditis virus (EMCV) infection, as well as long segments of the
reovirus dsRNA genome, can trigger MDA5-dependent IFN pro-
duction (Kato et al., 2008). The dependence of MDA5 activation
on dsRNA length might have evolved as a means of self-nonself
discrimination because short base-paired RNAs, such as regula-
tory RNAs or transcripts from retrotransposons, are present in
uninfected cells (Huang et al., 2012a). The precise nature of the
MDA5 agonist in infected cells might actually be more complex
than dsRNA and comprise structures that are produced asImmunity 38, May 23, 2013 ª2013 Elsevier Inc. 857
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Reviewintermediates during the replication of some RNA viruses (such
as EMCV and coxsackievirus) or as a result of convergent tran-
scription of DNA viruses (like vaccinia virus) (Feng et al., 2012;
Pichlmair et al., 2009; Triantafilou et al., 2012).
Recent work has pointed to the possibility that MDA5, like
RIG-I, could distinguish self- and nonself-RNA by features pre-
sent in the 50 end of RNA. Indeed, it was shown that viral mutants
lacking the ability to 20-O-methylate the 50 cap structure of their
mRNAs can induce type I IFN induction via MDA5 (Zu¨st et al.,
2011). This suggests that 20-O-methylation of the 50 cap struc-
ture, a conserved feature of all host mRNAs, could have evolved
as a self-marker. Whether MDA5 binds to non-20-O-methylated
mRNA to mediate downstream signaling remains to be deter-
mined, especially given that MDA5 has been shown to bind to
dsRNA stems rather than to caps (Wu et al., 2013a).
Much less is known of the nature of RNAs that might bind to
LGP2, the third RLR family member with no autonomous
signaling capacity. Some in vitro studies have shown that
LGP2 can bind dsRNA, 50 PPP RNA, and hepatitis C virus
(HCV) genomes (Bruns and Horvath, 2012). A focus on the
RNAs that bind to LGP2 might help decipher the true function
of this RLR.
RLR Activation
Crystal structures comparing ligand-free and ligand-bound
complexes have unveiled themechanism bywhich RIG-I is regu-
lated and recognizes RNA to trigger the downstream signaling
cascade that leads to type I IFN induction (Leung and Amara-
singhe, 2012). At resting state, RIG-I adopts a closed autoinhi-
bited conformation where the CARDs are sterically unavailable
for signal transduction (Civril et al., 2011; Ferrage et al., 2012;
Kowalinski et al., 2011) (Figure 2B). The rigid autoinhibited state
of RIG-I is thought to be achieved via a series of domain interac-
tions: both CARDs are linked to one another in a head-to-tail
manner (C terminus of CARD1 with the N terminus of CARD2),
and CARD2 also contacts the Hel2i domain (Civril et al., 2011;
Ferrage et al., 2012; Kowalinski et al., 2011). Upon infection,
RIG-I activation occurs in a dramatic and well-orchestrated
sequence of events (Figure 2B). A structural zinc ion and a posi-
tively charged cleft-like structure within the CTD specifically
recognize the 50 PPP extremity of blunt-end base-paired RNA
(Leung and Amarasinghe, 2012). Binding at the CTD is commu-
nicated N-terminally via a long and flexible elbow-like or
V-shaped ‘‘pincer’’ (P) domain (also known as the bridging heli-
ces) that connects the Hel1 domain to the CTD (Jiang et al.,
2011b; Kowalinski et al., 2011; Luo et al., 2011). At the same
time, the helicase domain binds to the duplexed-RNA sugar-
phosphate backbone in a ring-shaped clamp, which is further
compacted upon ATP hydrolysis (Jiang et al., 2011a; Kowalinski
et al., 2011; Luo et al., 2012). The interaction between the heli-
case domain and RNA releases the CARDs, and the P domain
functions as a nanomechanical camshaft to ‘‘push’’ them
away. Lys172 of the free CARD2 is now available for the addition
of polyubiquitin chains generated by the E3 ligase TRIM25
(tripartite-motif-containing 25), although it remains unclear
whether those chains are bound covalently or noncovalently
(Gack et al., 2007; Zeng et al., 2010). Whichever the case, the
ubiquitylation of RIG-I is thought to trigger the formation of a
large heterotetrameric complex—consisting of four RIG-I mole-858 Immunity 38, May 23, 2013 ª2013 Elsevier Inc.cules and four ubiquitin chains—that acts as the basic unit for
downstream signaling (Jiang et al., 2012) (Figure 2B).
As for RIG-I, the CTDs of LGP2 andMDA5 facilitate RNA bind-
ing, and the domain architecture of RIG-I is preserved in MDA5
and LGP2 (Leung and Amarasinghe, 2012). Although information
on LGP2 function and activation remains scarce, structural data
are beginning to unveil the basis of MDA5 recognition of dsRNA.
In contrast to the RIG-I CARDs, the MDA5 CARDs do not form a
stable interaction with the helicase domain at steady state, and
MDA5 is therefore thought to adopt an open conformation in
the absence of ligand (Berke and Modis, 2012). Upon dsRNA
binding, the helicase domain of MDA5 forms a ring around the
phosphate backbone of the ligand (Wu et al., 2013a). However,
rather than being a closed O-ring-like structure, as in RIG-I, the
MDA5 ring is C shaped. This more open conformation is due to
a distinct orientation of the CTD, which is rotated by 20
compared to that of RIG-I, causing it to be aligned with the
dsRNA axis as opposed to forming a cap that closes the helicase
ring over the 50 PPP end of dsRNA (Wu et al., 2013a). Residues
on the flat surface of the CTD further permit stem-loop rather
than end-mediated recognition of dsRNA. Thus, the CTD pro-
vides the basis for recognition of distinct RNA structures by
RIG-I and MDA5.
The MDA5 CTD is additionally thought to facilitate the forma-
tion of MDA5-dsRNA filaments through cooperative dsRNA
recognition (Berke and Modis, 2012; Berke et al., 2012; Peisley
et al., 2011; 2012; Wu et al., 2013a). This causes MDA5 mono-
meric-helicase-CTD rings to become stacked along the RNA in
a head-to-tail filament. The CARDs (absent from current crystal
structures) are thought to be excluded from the filament core
(Berke and Modis, 2012; Wu et al., 2013b). MDA5 signaling
therefore differs from that of RIG-I in that it does not involve
CARD exposure. Rather, it is proposed that ATP hydrolysis trig-
gered upon ligand binding regulates the conformation of the
CARDs of stacked MDA5 monomers and that the CARDs are
thus caused to self-assemble into discrete patches that act as
the nuclei for downstream signaling (Wu et al., 2013a).
As for RIG-I, MDA5 downstream signaling has been argued to
require binding of unanchored K63-linked polyubiquitin to the
CARDs, although this observation has been disputed (Jiang
et al., 2012; Wu et al., 2013a). RIG-I Lys172 is not conserved in
MDA5, yet TRIM25 appears important for MDA5 signaling and
is hypothesized to provide specificity for the local delivery of
ubiquitin chains (Gack et al., 2007; Jiang et al., 2012; Zeng
et al., 2010). In addition to regulating signaling, ATPase activity
also regulates MDA5 stability on long versus short dsRNAs by
facilitating the dissociation of MDA5 from short RNAs, which,
as argued above, contributes to self-nonself RNA discrimination
(Berke and Modis, 2012; Peisley et al., 2011; Wu et al., 2013a).
RLR Signal Transduction via MAVS
Activated RIG-I and MDA5 induce downstream signaling by
binding to the mitochondrial adaptor MAVS (mitochondrial
antiviral signaling) (also known as IPS-1 [IFN-b promoter stimu-
lator 1], CARDIF [CARD-adaptor-inducing IFN-b], or VISA
[virus-induced signaling adaptor]) via a CARD-CARD-mediated
interaction (Takeuchi and Akira, 2010) (Figure 3). Although the
majority of MAVS is present on themitochondria, a small propor-
tion is located in the peroxisomes and is also present in the
virus
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Figure 3. RLR Signaling and Other Receptors Involved in Cytosolic
RNA Sensing
RIG-I and MDA5 signaling induces MAVS activation and oligomerization into a
prion-like aggregate, which activates the TBK1 and IKK kinases. This culmi-
nates in the activation of transcription factors NF-kB, IRF-3, and IRF-7, which
translocate to the nucleus and participate in the induction of antiviral genes,
including those that encode IFN-a and IFN-b. Other DExD/H-box helicases,
including DDX60, DHX9, DDX3, and the DDX1-DDX21-DHX36 complex, are
also reported sensors of cytosolic RNA. Most of these helicases are thought to
trigger IFN transcription by using RLR-dependent pathways (through RLRs
themselves, MAVS, or TBK1), but the DDX1-DDX21-DHX36 complex is
thought to signal through TRIF. HMGB proteins and NOD2 have also been
described as receptors for cytosolic RNA and inducers of IFN responses.
Lastly, it has been argued that after RNA stimulation, LRRFIP1 phosphorylates
b-catenin, which translocates to the nucleus and promotes IFN-b expression.
Dashed lines indicate indirect or possible signaling, and ‘‘p’’ indicates a
phosphorylated protein.
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brane (MAM) (Dixit et al., 2010; Horner et al., 2011). This has
led to the proposal that these structures act as platforms for anti-
viral signaling (Dixit et al., 2010; Horner et al., 2011). There is also
evidence of recognition of viral RNAs in stress granules, but how
this gets translated into signaling at MAMs or peroxisomes is
poorly understood (Onomoto et al., 2012).
Viral infection appears to induce the formation of large aggre-
gates ofMAVS, and it has recently been demonstrated that these
result from self-propagation in a prion-like manner (Hou et al.,
2011). In other words, the engagement of MAVS by RLRs causes
a conformational change that propagates to adjacent unen-
gaged MAVS and thereby results in a large-scale amplification
of the signaling cascade. This allows for highly sensitive detec-
tion of very small amounts of viral RNA, and it has been calcu-lated that <20molecules of 50 PPP viral RNA are sufficient to acti-
vate the RIG-I-MAVS pathway (Zeng et al., 2010). Several
cytosolic molecules that are also involved in other innate
signaling responses are subsequently recruited to MAVS prions
(Takeuchi and Akira, 2010). This complex allows for the activa-
tion of the kinases TBK1-IKKε (TANK-binding kinase 1-IkB ki-
nase-ε), responsible for the activation of IRF-3 and IRF-7 (IFN
regulatory factors 3 and 7, respectively), and IKKa and IKK-b,
responsible for NF-kB (nuclear factor kappa-light-chain
enhancer of activated B cells) activation (Figure 3). These tran-
scription factors translocate to the nucleus and coordinate the
expression of the genes encoding IFN-a and IFN-b, as well as
other antiviral genes (Takeuchi and Akira, 2010). In addition to
IRF-3 and IRF-7, IRF-5 might also induce type I IFN responses
downstream of MAVS in some dendritic cells (Lazear et al.,
2013).
Independently of MAVS, RIG-I has also been implicated in
activating the intracellular signaling complex termed the inflam-
masome, the activation of which leads to the proteolytic pro-
cessing of prointerleukin 1b (proIL-1b) into mature IL-1b, a proin-
flammatory cytokine (Abdullah et al., 2012; Poeck et al., 2010).
Finally, the activation of MDA5 or RIG-I in melanoma cells might
couple to the induction of caspase-dependent apoptotic re-
sponses via the BH3-only protein Noxa (Besch et al., 2009).
Modulation of RLR Signaling
Many proteins are reported to modulate the RLR signaling
pathway (Eisena¨cher and Krug, 2012). One class is those
that regulate the posttranslational status and lifetime of
RLRs. Like TRIM25, the E3 ligase Riplet (also known as
RNF135 or REUL) can trigger K63-linked polyubiquitylation of
RIG-I and positively affect antiviral signaling (Oshiumi et al.,
2012). Others, including RNF125 (ring-finger protein 125),
Smurf1, AIP4, and c-Cbl, negatively regulate RIG-I, MDA5,
and/or MAVS signaling by targeting them for proteasomal degra-
dation (Eisena¨cher and Krug, 2012; Chen et al., 2013b; Wang
et al., 2012a). Deubiquitylating enzymes such as CYLD (cylindro-
matosis) and USP4 (ubiquitin-specific protease 4) can also regu-
late RIG-I responses by removing K63-linked or K48-linked poly-
ubiquitin chains, respectively (Friedman et al., 2008; Wang et al.,
2013). Phosphorylation and SUMOylation have additionally been
reported to regulate RIG-I and MDA5 function (Ferrage et al.,
2012; Gack et al., 2010; Mi et al., 2010; Nistal-Villa´n et al.,
2010; Wies et al., 2013).
A different class of RLR regulators is mitochondrial proteins.
Two homologous regulators of mitochondrial fusion, MFN1 and
MFN2 (mitofusin 1 and 2, respectively), interact with MAVS but
have opposing effects. Whereas MFN2 directly inhibits MAVS,
MFN1 was suggested to positively regulate RLR-mediated
innate antiviral responses by affecting mitochondrial dynamics
(Arnoult et al., 2011). Targeted deletion of both MFN1 and
MFN2 was shown to result in impaired mitochondrial fusion
and decreased mitochondrial-membrane potential, which corre-
lated with a defective antiviral response (Koshiba et al., 2011). In
addition, the mitochondrial NLR (Nod-like receptor) protein
NLRX1 (also known asNOD5) has been reported to constitutively
interact with MAVS and inhibit RLR signaling (Xiao and Ting,
2012). NLRX1 has also been shown to partner with TUFM (mito-
chondrial Tu translation elongation factor) to promoteImmunity 38, May 23, 2013 ª2013 Elsevier Inc. 859
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et al., 2012; 2013). Whether the RNA binding capacity of
NLRX1 is important in regulating RLR responses remains to be
investigated (Hong et al., 2012). However, the function of
NLRX1 is controversial, given that two out of three strains of
NLRX1-deficient mice fail to display any alteration of MAVS
signaling (Allen et al., 2011; Rebsamen et al., 2011; Soares
et al., 2012). Similarly ambiguous results have been reported
for a second NLR, NLRC5 (also known as NOD4), which has var-
iably been reported to inhibit RIG-I and/or MDA5 or to have no
function in RLR signaling (Cui et al., 2010; Kumar et al., 2011a).
The precise role of NLRX1 and NLRC5 in antiviral immunity will
need to be clarified in future studies.
The third class of regulators includes miscellaneous proteins
such as SHP-1 (Src homology phosphatase 1) and EYA4 (eyes
absent 4), as well as Ankrd17 (ankyrin repeat protein 17), the
scaffold protein 14-3-3ε, the dsRNA binding protein PACT, and
ZAPS (zinc-finger CCCH-type antiviral protein 1), all of which
are reported to enhance RLR signaling (An et al., 2008; Haya-
kawa et al., 2011; Kok et al., 2011; Liu et al., 2012; Okabe
et al., 2009; Wang et al., 2012b). The ribonucleoprotein PTB-
binding 1 (RAVER1) was also found to specifically regulate
MDA5 activation (Chen et al., 2013a). Focal adhesion kinase
(FAK) and the complement receptor gC1qR appear to translo-
cate to the mitochondria to interact with MAVS. Whereas FAK
acts as a positive regulator, gC1qR has been found to inhibit
RLR signaling (Bozym et al., 2012; Xu et al., 2009). Tetraspanin
6 can also negatively affect RLR signaling in that it can associate
with MAVS and interfere with the recruitment of TRAF3
(Wang et al., 2012c). In sum, RLR signaling is subject to a com-
plex system of posttranslational regulation, as well as regulation
by other cellular proteins. The large number of RLR regulators
underlines the importance of these receptors in antiviral re-
sponses and the severe consequences that might ensue from
their misfiring.
Other Proteins Implicated in Cytosolic Sensing of Viral
RNA
Additional DExD/H-box helicases outside the RLR helicase sub-
family have been implicated in the IFN-a and IFN-b response to
viruses. They include DDX3 (also known as DDX3X or DBX),
DHX9 (also known as RHA [RNA helicase A]), DDX60 (also known
as DHX60), and the DDX1-DDX21-DHX36 complex. These heli-
cases are thought to mediate IFN-a and IFN-b expression either
by directly sensing nucleic acids after viral infection and/or by
interacting with components of the IFN-a and IFN-b induction
pathway (Figure 3).
DDX3 and DHX9 are constitutively expressed and have been
proposed to play a role in the early phases of viral infection
when RLR levels have yet to be upregulated by IFNs (Oshiumi
et al., 2010; Zhang et al., 2011d). These helicases are thought
to sense viral RNA, couple to MAVS, and induce IFN expression
(Oshiumi et al., 2010; Zhang et al., 2011d). In addition to
sensing RNA, DDX3 is reported to precipitate with RIG-I,
MDA5, TBK1, and IKKε, as well as associate with the Ifnb1 pro-
moter (Gu et al., 2013; Oshiumi et al., 2010; Schro¨der et al.,
2008; Soulat et al., 2008). Overexpression and knockdown
studies suggest that DDX3 and DHX9 are required for the full
induction of IFN responses to a number of RNA viruses and860 Immunity 38, May 23, 2013 ª2013 Elsevier Inc.poly(I:C) (Oshiumi et al., 2010; Schro¨der et al., 2008; Zhang
et al., 2011d).
Another helicase, DDX60, has been proposed to promote the
antiviral response at the level of RLRs (Miyashita et al., 2011).
DDX60 is a member of the Ski2-like subfamily of DExD/H-box
helicases, but unlike DDX3 and DHX9 expression, its expression
is not constitutive but induced by IFNs, similar to RLRs. Coimmu-
noprecipitation studies have shown that DDX60 binds to nucleic
acids and have identified RIG-I, MDA5, LGP2 as interacting part-
ners (Miyashita et al., 2011). Furthermore, cells in which DDX60
expression was stably knocked down produced lower levels of
mRNA for IFN-b and ISGs in response to both RNA and DNA
stimuli (Miyashita et al., 2011). Because DDX60 expression
also appeared to increase binding of RNA to RIG-I, it was hy-
pothesized that this helicase might bind viral RNA and associate
with RLRs during viral infections to enhance signaling (Miyashita
et al., 2011). However, we have failed to reproduce such data
and have found no role for DDX60 in IFN induction either
in vitro or in a DDX60-deficient mouse (data not shown). Rather,
DDX60 appears to be an ISG that acts as a virus-specific restric-
tion factor and whose overexpression in cultured cells can
restrict the replication of HCV, but not yellow fever virus, WNV,
Chikungunya virus, Venezuelan equine encephalitis virus, or
HIV-1 (Schoggins et al., 2011).
A cytosolic triple-helicase complex formed by DDX1, DDX21,
and DHX36 is also reported to sense RNA in myeloid cells yet
function independently of the RLR pathway to induce IFNs
(Zhang et al., 2011b). DDX1 is suggested to directly bind
poly(I:C), whereas DDX21 and DHX36 are thought to interact
with the adaptor TRIF (TIR-domain-containing adaptor-inducing
IFN-b) to mediate downstream signaling. Targeted knockdown
of any of the helicases negatively affects the IFN-response to
poly(I:C), influenza virus, and reovirus. Lastly, two proteins that
are not RNA helicases have also been implicated in the sensing
of cytosolic RNA and subsequent IFN induction. These include
the HMGB (high-mobility-group box) proteins, leucine-rich-
repeat protein LRRFIP1 (leucine-rich repeat in flightless interact-
ing protein 1), and the NLR NOD2 (nucleotide-binding oligomer-
ization domain 2) (Sabbah et al., 2009; Yanai et al., 2009; Yang
et al., 2010). The functional relevance of all of these proteins in
detecting cytosolic RNA requires further investigation for
defining whether these molecules work in concert with RLRs in
regulating IFN responses and how this might occur.
RLRs in Development and Disease
In addition to playing a role in innate antiviral signaling, RLRs
have been implicated in shaping adaptive immunity, including
regulating the magnitude and quality of T cells and antibody re-
sponses (Negishi et al., 2012; Suthar et al., 2012; Wang et al.,
2007). Indeed, a recent study has defined a cell-autonomous
role for LGP2 in regulating CD8+ T cell survival and fitness during
WNV infection (Suthar et al., 2012). Interestingly, the first RIG-I-
deficient mouse strain generated showed liver degeneration
and embryonic lethality at day 12.5, suggesting that RIG-I could
be involved in development (Kato et al., 2005). Curiously, this
phenotype is different from that observed in a second RIG-I-defi-
cient mouse, which is viable, fertile, and born at Mendelian ratios
but exhibits a progressive myeloproliferative disorder, as well as
increased susceptibility to dextran-sulfate-sodium-induced
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has also been seen in MAVS-deficient mice and might be ex-
plained by the fact that the RIG-I-MAVS pathway responds to
RNA from commensal bacteria to reinforce gut-barrier protec-
tion (Li et al., 2011).
RLRs have been linked to inflammatory disorders besides co-
litis. IFIH1, which encodes MDA5, was implicated in type I dia-
betes through genome-wide association studies (Lind et al.,
2012). Whereas loss-of-function alleles of IFIH1 confer disease
protection, susceptibility genotypes are associated with
increased IFIH1 expression levels, which possibly cause exacer-
bation of ongoing immune pathology (Lind et al., 2012).
Conversely, MDA5 was recently shown to play a protective
role in virus-induced diabetes in mice after infection with
EMCV, a virus with a tropism for the insulin-producing b cells
(McCartney et al., 2011). MDA5-deficient mice and cells also
show increased susceptibility to infections with coxsackie type
B virus, a Picornaviridae family enterovirus that has been impli-
cated in the onset and progression of type I diabetes in humans
(Lind et al., 2012) (Table S1). Therefore, investigating how human
responses to enteroviruses are affected by SNPs associated
with type I diabetes might help to elucidate the function of
MDA5 in the development of this disease (Lind et al., 2012). Addi-
tional genetic associations between IFIH1 and other immune
diseases have been reported and include systemic lupus erythe-
matosus (SLE), psoriasis, and immunoglobulin A deficiency (Lind
et al., 2012).
The Interferon Response to Cytosolic DNA
As for RNA, there are cytosolic pathways dedicated to the recog-
nition of DNA (reviewed in detail by Paludan and Bowie, 2013, in
this issue). Multiple studies have shown that the introduction of
dsDNA into the cytosol of cells induces IFN-a and IFN-b in a
TLR-independent fashion (Cavlar et al., 2012). This can happen
naturally during infection with DNA viruses (such as HSV-1 or
vaccinia virus), bacteria (such as Listeria monocytogenes or
Legionella pneumophila), or parasites (like Plasmodium falcipa-
rum) or can be mimicked experimentally by the transfection of
natural or synthetic DNA. Commonly used types of immunosti-
mulatory B-DNA are poly(dA:dT), a homocopolymer, and ISD
(immune-stimulatory DNA), a synthetic double-stranded 45 bp
oligonucleotide lacking contiguous CpG sequences (Cavlar
et al., 2012). In addition to synthetic and microbial DNA, host
DNA present in the cell cytosol can also induce the expression
of IFNs. Evidence for this stems from the observation that func-
tional loss of certain deoxyribonucleases (DNases) can precipi-
tate interferonopathies, including SLE and Aicardi-Goutie`res
syndrome in humans (Crow, 2011). For example, mice or hu-
mans lacking 30 repair exonuclease TREX1 (three prime repair
exonuclease 1), a cytosolic DNase, cannot degrade endoge-
nous-retroelement-derived cDNA, which accumulates in the
cytosol and triggers IFN-a and IFN-b and autoimmunity (Crow,
2011). As such, it appears that the mere presence of DNA in
the cytoplasm, normally a DNA-free environment, is sufficient
to activate innate immune signaling. Although there is also a sug-
gestion that DNA sensing might additionally occur in the nucleus
(Kerur et al., 2011; Li et al., 2012), efforts have focused on iden-
tifying the pathways that mediate the sensing of DNA in the cell
cytosol and link it to inflammation (Figure 4).Initial conflicting data reporting a role for MAVS as an adaptor
in the cytosolic DNA response led to the discovery of RIG-I as an
‘‘indirect’’ sensor of some types of DNA (Ablasser et al., 2009;
Chiu et al., 2009) (Figure 4). Two groups demonstrated that cyto-
solic AT-rich DNA, such as poly(dA:dT), can be transcribed in the
cytosol by RNA polymerase (pol) III into uncapped 50 PPP-RNA,
which then functions as a RIG-I agonist (Ablasser et al., 2009;
Chiu et al., 2009). The pathway involving RNA pol III and RIG-I
was shown to be required for sensing RNA encoded with
Epstein-Barr virus and the induction of a full IFN response after
infections with HSV-1 and adenovirus, as well as the intracellular
bacteria L. pneumophila and L. monocytogenes (Abdullah et al.,
2012; Ablasser et al., 2009; Chiu et al., 2009) (Table S1). Howev-
er, the findings obtained with HSV-1 and L. pneumophila have
not been validated in further reports, and additional studies are
required for determining the true relevance of the pathway
involving RIG-I and RNA pol III for pathogen detection (Melch-
jorsen et al., 2010; Monroe et al., 2009).
The ER-localized protein STING (stimulator of IFN genes) (also
known as TMEM173 [transmembrane protein 173], MITA [medi-
ator of IRF3 activation], MPYS [methionine-proline-tyrosine-
serine], and ERIS [ER IFN stimulator]) is essential for the RNA-
pol-III-independent IFN response to cytosolic DNA (Cavlar
et al., 2012; Ishikawa et al., 2009) (Figure 4). STING-deficient
cells show a complete abrogation of IFN-b production in
response to a variety of DNA stimuli of bacterial, viral, parasitic,
or synthetic origin (Cavlar et al., 2012). Some studies have also
reported a decrease in IFN induction in STING-deficient cells in-
fected with RNA viruses (Ishikawa and Barber, 2008; Ishikawa
et al., 2009; Jin et al., 2008; Sun et al., 2009; Zhong et al.,
2008), whereas others have found no difference (Chen et al.,
2011; Sauer et al., 2011). These discrepancies might be attribut-
able to another function of STING, which is independent of RNA
or DNA recognition, in inducing IFNs and ISGs upon fusion of
viral envelopes with target cells (Holm et al., 2012). Finally,
STING further acts as a sensor for the prokaryotic second
messenger molecules cyclic-di-GMP and cyclic-di-AMP
(Burdette et al., 2011; Huang et al., 2012b; Jin et al., 2011;
Ouyang et al., 2012; Sauer et al., 2011; Yin et al., 2012) and the
chemotherapeutic agent 5,6-dimethylxanthenone-4-acetic acid
(Brunette et al., 2012; Prantner et al., 2012).
STING signaling is thought to be controlled by K63-linked
ubiquitylation by both TRIM56 (tripartite motif 56) and TRIM32
(tripartite motif 32) (Tsuchida et al., 2010; Zhang et al., 2012).
After dsDNA stimulation, STING rapidly traffics from the ER
through the Golgi into perinuclear punctate structures that also
contain the kinase TBK1 (Ishikawa et al., 2009; Saitoh et al.,
2009; Tanaka and Chen, 2012). STING appears to function as
a scaffold for downstream activation by bringing IRF-3 in close
proximity to TBK1, which then is able to phosphorylate it (Tanaka
and Chen, 2012). Inappropriate activation of STING (encoded by
Tmem173) leads to the development of autoimmunity associ-
ated with Trex1 or DNaseII mutations, and Trex1/
Tmem173/ mice are completely protected from mortality
and autoimmune tissue damage (Gall et al., 2012). Protection
from anemia and polyarthritis has also been reported in animals
deficient in both DNaseII and STING (Ahn et al., 2012). These
data indicate that the STING pathway is triggered by both foreign
DNA and self-DNA.Immunity 38, May 23, 2013 ª2013 Elsevier Inc. 861
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Figure 4. Putative Intracellular DNA
Sensors Involved in IFN-a and IFN-b
Induction
DNA present in the cytosol after viral infection in-
duces the production of type I IFNs through a
central signaling cascade involving STING, which
serves as a scaffold for the phosphorylation of
IRF-3 by the kinase TBK1. It was recently
demonstrated that the cytosolic nucleotidyl-
transferase cGAS binds DNA and synthesizes the
formation of a cyclic-GMP and cyclic-AMP hybrid
termed cGAMP, which directly binds to and acti-
vates STING. Cytosolic DNA is reported to engage
a number of additional receptors, including DAI,
human IFI16 (or mouse p204), and the helicases
DDX41, DHX36, and DHX9. DHX36 and DHX9
appear to be specific to CpG DNA and are re-
ported to signal via MyD88. HMGB1, HMGB2, and
HMGB3 have also been shown to promote cyto-
solic DNA responses. Data also suggest that
ABCF1 binds DNA and interacts with HMGB2 and
p204 to stimulate innate immune responses.
Moreover, AT-rich DNA can be transcribed byRNA
pol III into 50-PPP-containing RNA (50 PPP RNA),
which serves as a RIG-I agonist. LRRFIP1 senses
cytosolic DNA and phosphorylates b-catenin,
which translocates to the nucleus and promotes
IFN-b transcription. The DNA-PKc-Ku70-Ku80
and MRE11-RAD50 complexes, involved in DNA-
damage responses, have additionally been
suggested to bind cytosolic DNA and promote
STING-dependent type I IFN responses. Ku70 is
further reported to trigger the expression of type III
IFNs in an IRF-1- or IRF-7-dependent manner in
response to cytosolic DNA (not depicted; Zhang
et al., 2011a). Proteins involved in DNA-damage
responses, as well as IFI16 and RNA pol III, are
abundantly present in the nucleus, highlighting the
possibility that DNA sensing might also occur in
that organelle (only depicted here for IFI16).
Dashed lines indicate indirect or possible
signaling, and ‘‘p’’ indicates phosphorylated
proteins.
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There has been considerable effort to try to elucidate the very
initial signaling events that permit cells to detect the presence
of cytosolic DNA and engage STING. This search has led to
the identification of multiple DNA sensors (Figure 4). The IFN-
inducible protein DAI was the first protein reported as a potential
mediator of the IFN response to cytosolic DNA (Takaoka et al.,
2007). LRRFIP1, HMGB proteins, and ABCF1 (ATP-binding
cassette, subfamily F member 1) have also been shown to bind
DNA directly and positively regulate IFN responses (Lee et al.,
2013; Yanai et al., 2009; Yang et al., 2010). The AIM2-like pro-
teins, including human IFI16 and its mouse ortholog p204,
have also been implicated in STING-dependent IFN responses
(Brunette et al., 2012; Unterholzner et al., 2010). Moreover,
some DExD/H-box helicases, including DDX41, DHX9 and
DDX36, are also postulated to act as sensors of cytosolic DNA
(Kim et al., 2010; Zhang et al., 2011c). Lastly, some proteins
with known functions in DNA-damage responses have also
been reported as mediators of the antiviral response triggered
by cytosolic DNA. These include components of the DNA-PK
(DNA-dependent protein kinase; composed of Ku70, Ku80,
and DNA-PKc) and MRE11 (meiotic recombination 11 homolog
A)-RAD50 complexes (Ferguson et al., 2012; Kondo et al.,862 Immunity 38, May 23, 2013 ª2013 Elsevier Inc.2013; Zhang et al., 2011a). The lack of redundancy among these
receptors, as well as their role in other cellular functions, has led
to the hypothesis that they might function as cytosolic DNA sen-
sors only in certain cell types and/or in response to certain path-
ogens (Paludan and Bowie, 2013, in this issue).
A recent study has suggested that themolecule responsible for
binding and activating STING after DNA transfection or infection
with aDNAvirusmight not beDNA itself but rather a novel second
messenger termed cyclic-GMP-AMP (cGAMP) (Wu et al., 2013b)
(Figure 4). The ability of STING to directly bind eukaryotic cGAMP
is reminiscent of its reported aditional function as a sensor of
prokaryotic cyclic-di-GMP and cyclic-di-AMP (see above) and
suggests that the key DNA sensor is a DNA-dependent cytosolic
cyclase. Consistent with that prediction, a newly identified nucle-
otidyltransferase family member, named cytosolic GAMP syn-
thase (or cGAS),was shown tomediate the production of cGAMP
in response to DNA (Sun et al., 2013). The identification of the
cGAS-cGAMP-STING pathway is an exciting development that
offers a new perspective in DNA sensing, but it remains to be
established to what extent it can account for responses to path-
ogen infection. It will also be important to investigatewhether and
how other DNA sensors function in concert with cGAS to
promote cytosolic DNA responses.
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Although hosts have developed a complex immune system to
fend off invaders, viruses have counteracted with a series of so-
phisticated mechanisms to successfully replicate within host
cells. In this final section, we describe some of the ways in which
viruses escape and block cell-intrinsic detection or use it to their
advantage.
One strategy viruses employ to evade innate immune detec-
tion is by modifying and concealing their genomes and replica-
tion intermediates. For example, some negative-strand RNA
viruses, such as Hantaan virus, Crimean-Congo haemorrhagic
fever virus (Nairovirus), Prospect Hill virus (all Bunyaviridae),
and Borna disease virus (BDV; Bornaviridae), avoid RIG-I recog-
nition by using virus-encoded endonucleases or phosphatases
to process the 50 PPP of their genomes to a 50 monophosphate
(Garcin et al., 1995; Habjan et al., 2008; Wang et al., 2011b;
Weber et al., 2013). In addition to having a 50 monophosphate,
the majority of genomes and antigenomes of BDV have a 30
overhang as a result of trimming of the 50 end, making them re-
fractory to RIG-I detection (Schlee et al., 2009; Schmidt et al.,
2009; Schneider et al., 2007). Similarly, Arenaviridae (which
include Lassa virus and Tacaribe arenavirus) have PPPs on their
genomes but contain a 50 nucleotide overhang (PPP-G), which
has been shown to interfere with RIG-I recognition (Marq
et al., 2010; Schlee et al., 2009; Schmidt et al., 2009). More
recent data suggest that the genomes of these viruses could
also act as RIG-I decoys by binding the receptor but failing to
cause its activation (Marq et al., 2011). In contrast, Picornaviri-
dae and Caliciviridae have positive ssRNA genomes that are
covalently bound to a viral protein, VPg (viral genome-linked
protein), and are therefore not subjected to RIG-I recognition
(Knipe and Howley, 2007). Another way in which viruses avoid
RLR sensing is by hiding their genomes. Certain RNA and
DNA viruses, like Orthmomyxoviridae and Adenoviridae,
respectively, replicate in the nucleus, a location that is not sub-
jected to surveillance by cytosolic PRRs (Knipe and Howley,
2007). Most RNA and some DNA viruses that replicate in the
cytoplasm do so in specific compartments composed of both
viral- and host-encoded proteins, often in association with cyto-
solic membranes or organelles such as the mitochondria, ER,
and Golgi (Knipe and Howley, 2007). These structures act as
viral factories to facilitate the production of virions while seques-
tering viral RNA or DNA away from innate immune sensors. Spe-
cific viral proteins can also help sequester viral nucleic acids
and outcompete PRRs. For example, the influenza nonstruc-
tural protein 1 (NS1), the vaccinia virus protein E3, and Ebola
virus protein VP35 allow these viruses to disrupt immunity in
multiple ways, including through binding of viral RNA, to avoid
PRR detection (Leung et al., 2012). Recent structural studies
have demonstrated that VP35 binding to viral RNA mimics
that of RIG-I and provides an effective mechanism for excluding
the sensor (Leung et al., 2012). In contrast, the C protein of the
human parainfluenza virus type 1 functions somewhat differ-
ently. Rather than sequester viral RNA, it is thought to suppress
the accumulation of dsRNA that would otherwise trigger MDA5
(Boonyaratanakornkit et al., 2011). Finally, HIV manages to
evade immune detection by benefiting from the functions of
the host protein, TREX1. This exonuclease degrades uninte-
grated HIV cDNA after cytosolic reverse transcription, allowingits escape from detection by cytosolic DNA sensors (Yan and
Chen, 2012).
A second distinct strategy used by viruses to evade cell-
intrinsic detection is direct targeting and inhibition of cytosolic
PRRs and downstream signaling molecules (Leung et al.,
2012; Taylor and Mossman, 2013). For example, NS1 from
influenza interacts with RIG-I and efficiently antagonizes down-
stream signaling, in part by disrupting TRIM25 and Riplet ubiq-
uitin E3 ligases (Garcı´a-Sastre, 2011; Leung et al., 2012). Other
viruses encode deubiquitinating enzymes that target RIG-I or
can harness negative-feedback loops of RIG-I signaling (Inn
et al., 2011; Sun et al., 2012; van Kasteren et al., 2012; Wang
et al., 2011a). Viruses have also been shown to decrease RLR
and MAVS levels by lysosomal targeting, sequestration into viral
inclusion bodies, and transcriptional downregulation (Taylor and
Mossman, 2013). In addition, paramyxoviruses directly block all
three RLRs via their V and C proteins (Goodbourn and Randall,
2009). A recent structure of the porcine MDA5 helicase domain
in complex with the V protein of parainfluenza virus 5 revealed
that the V protein binds and disrupts the MDA5 ATPase domain
and thus inhibits the cooperative assembly of MDA5-dsRNA fil-
aments (Motz et al., 2013). Picornaviridae have come up with a
more dramatic strategy: they trigger MDA5 and RIG-I cleavage
and degradation by using the cell’s caspase and proteasome
machinery and the viral protease 3Cpro (Barral et al., 2007;
2009). MAVS is also a target for coxsackievirus-B3-encoded
3Cpro (Mukherjee et al., 2011) and the hepatitis B virus (Hepad-
naviridae) viral protein HBx (hepatitis B virus X) (Kumar et al.,
2011b; Wei et al., 2010). In addition, MAVS can be cleaved off
mitochondria by the serine protease NS3-4A of HCV (Flaviviri-
dae) and the ABC cysteine protease of hepatitis A virus (Picor-
naviridae) (Li et al., 2005; Meylan et al., 2005). Finally, the three
polymerase subunits (PB1, PB2, and PA) and PB1-F2 of
influenza virus can also bind MAVS and inhibit the induction of
type I IFNs (Graef et al., 2010; Iwai et al., 2010; Varga et al.,
2012).
Given the more recent identification of the receptors involved
in sensing cytosolic DNA, viral proteins thought to inhibit these
PRRs are only just beginning to emerge. There is work suggest-
ing that viral proteins encoded by members of the Herpesviridae
family inhibit DAI, DHX9, and IFI16 responses. Recently, it was
shown that the HSV-1-encoded protein ICP0 targets the degra-
dation and nuclear relocalization of IFI16 and thereby limits IRF-3
activation (Orzalli et al., 2012). The human CMV matrix protein
pUL83 (pp65), which is a known inhibitor of ISG induction and
an important virulence factor, has been shown to interact with
IFI16 (Cristea et al., 2010). Moreover, the murine CMV viral inhib-
itor of RIP activation (encoded by M45) and the KSHV viral pro-
tein kinase are thought to target DAI and DHX9 responses,
respectively (Jong et al., 2010; Rebsamen et al., 2009; Upton
et al., 2012; Welz and Pasparakis, 2012). Other viral proteases,
including the coronavirus papain-like proteases and the DENV
NS2B3 protease, target STING directly (Aguirre et al., 2012;
Sun et al., 2012; Yu et al., 2012). The proteolytic activity of
NS2B3 appears to be species specific given that it has been
shown to cleave human, but not murine, STING (Aguirre et al.,
2012; Yu et al., 2012). Nevertheless, targeting of STING by
some RNA viruses suggests that it serves as an important anti-
viral factor for both DNA and RNA viruses.Immunity 38, May 23, 2013 ª2013 Elsevier Inc. 863
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Cells are equippedwith systems that allow them to rapidly detect
the presence of viral intruders and coordinate antiviral defense
programs. In this review, we have highlighted recent advances
in our understanding of how viral nucleic acids are detected
inside the cell and activate innate immune defenses. RNA sen-
sors, such as MDA5 and RIG-I, discriminate self-RNA from
foreign RNA present in the cytosol by binding specific RNA
structures, such as long dsRNA or 50 PPP base-paired extrem-
ities, which are only found upon viral invasion. The molecular ba-
sis for this ligand specificity has been revealed by structural
studies that further elucidate how ligand binding can result in
signal transduction. Analysis of the latter has led to the discovery
of a MAVS-mediated self-propagating signal that confers
remarkable sensitivity to low levels of viral RNA and results in
the induction of an IFN-mediated positive-feedback loop that re-
inforces antiviral immunity. Further studies have indicated that
the system is highly regulated to prevent autoimmune disease
and is targeted by viruses to permit their replication. Finally,
emerging work has shown that DNA can also be sensed in the
cytosol of cells and that this detection involves both novel and
previously described proteins, as well as second messengers,
such as cGAMP, that had not been known to be produced in eu-
karyotic cells. Thus, in little under a decade, we have gone from
knowing very little about cytosolic detection of viruses to having
a rich understanding. However, this understanding is by no
means comprehensive. The spatiotemporal aspects of cytosolic
viral detection remain mysterious and will need to be elucidated
via mapping the viral life cycle with respect to immune activation
in infected cells. Further progress is needed for defining the true
nature of RLR agonists, particularly in cells infected with viruses
recognized by both RIG-I and MDA5 and in which these two hel-
icases might detect distinct RNA species present at different
times during virus replication. Little is known about the detection
of DNA and whether self-nonself DNA discrimination is simply
based on nuclear versus cytoplasmic localization. Even if the
latter is true, it will be important to determine how it is regulated
in mitotic cells upon disintegration of the nuclear envelope.
Finally, understanding how the triggering of multiple PRRs is in-
tegrated during viral infection and how this dictates host immu-
nity remains an important issue. Thus, molecular and cellular
understanding of cell-intrinsic virus detection and its evasion
promises to continue to be a rich area for future study, which
will help clarify immune mechanisms of self-nonself discrimina-
tion andmight lead to novel strategies for intervention in viral dis-
ease pathogenesis.SUPPLEMENTAL INFORMATION
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